pcDNA cyclin D1 HA T286A Citations (12)

Originally described in: Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression.
Newman RM, Mobascher A, Mangold U, Koike C, Diah S, Schmidt M, Finley D, Zetter BR J Biol Chem. 2004 Oct 1. 279(40):41504-11. PubMed Journal

---

Articles Citing pcDNA cyclin D1 HA T286A

Articles
F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Santra MK, Wajapeyee N, Green MR. Nature. 2009 Jun 4. 459(7247):722-5. PubMed
Notch induces cyclin-D1-dependent proliferation during a specific temporal window of neural differentiation in ES cells. Das D, Lanner F, Main H, Andersson ER, Bergmann O, Sahlgren C, Heldring N, Hermanson O, Hansson EM, Lendahl U. Dev Biol. 2010 Dec 15;348(2):153-66. doi: 10.1016/j.ydbio.2010.09.018. Epub 2010 Sep 29. PubMed
SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. Mittal MK, Singh K, Misra S, Chaudhuri G. J Biol Chem. 2011 Jan 7;286(1):469-79. doi: 10.1074/jbc.M110.164384. Epub 2010 Nov 2. PubMed
Outgrowth of single oncogene-expressing cells from suppressive epithelial environments. Leung CT, Brugge JS. Nature. 2012 Feb 8;482(7385):410-3. doi: 10.1038/nature10826. PubMed
Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity. Reiner T, Parrondo R, de Las Pozas A, Palenzuela D, Perez-Stable C. PLoS One. 2013;8(2):e56234. doi: 10.1371/journal.pone.0056234. Epub 2013 Feb 12. PubMed
PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells. Yang Y, Wu J, Cai J, He Z, Yuan J, Zhu X, Li Y, Li M, Guan H. Int J Cancer. 2015 Feb 15;136(4):E39-50. doi: 10.1002/ijc.29150. Epub 2014 Sep 2. PubMed
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma. Mohanty A, Sandoval N, Das M, Pillai R, Chen L, Chen RW, Amin HM, Wang M, Marcucci G, Weisenburger DD, Rosen ST, Pham LV, Ngo VN. Oncotarget. 2016 Nov 8;7(45):73558-73572. doi: 10.18632/oncotarget.12434. PubMed
Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells. Wang N, Wang X, Tan HY, Li S, Tsang CM, Tsao SW, Feng Y. Int J Mol Sci. 2016 Nov 15;17(11). pii: E1899. PubMed
QuPath: Open source software for digital pathology image analysis. Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW. Sci Rep. 2017 Dec 4;7(1):16878. doi: 10.1038/s41598-017-17204-5. PubMed
Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species- and GSK3beta-dependent mechanism. Samara A, Shapira S, Lubin I, Shpilberg O, Avigad S, Granot G, Raanani P. Br J Haematol. 2021 Feb;192(4):747-760. doi: 10.1111/bjh.17284. Epub 2021 Jan 31. PubMed
A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21. Belanger F, Roussel C, Sawchyn C, St-Hilaire E, Gezzar-Dandashi S, Kimenyi Ishimwe AB, Mallette FA, Wurtele H, Drobetsky E. J Biol Chem. 2023 Jul;299(7):104900. doi: 10.1016/j.jbc.2023.104900. Epub 2023 Jun 9. PubMed
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. Flores LF, Marks DL, Vera RE, Sigafoos AN, Tolosa EJ, Almada LL, Pease DR, Toruner MD, Chang B, Tader BR, LaRue-Nolan KC, Carr RM, Graham RP, Hagen CE, Brown MR, Matveyenko AV, Wilson KL, Dawson DW, Pin CL, Roux KJ, Fernandez-Zapico ME. JCI Insight. 2025 Jun 10;10(14):e187799. doi: 10.1172/jci.insight.187799. eCollection 2025 Jul 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.